Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

CLINICAL SPECTROSCOPY

CLINICAL SPECTROSCOPY The alarming increase of argyrosis leaves little doubt as to our purpose in this report. There has been an accumulation of indubitable clinical evidence which makes it imperative to present before those who prescribe, dispense or use these drugs the danger entailed therein. It must be emphasized that within the past year, following intranasal applications with Argyrol and Neo-Silvol in fifteen children under 10 years of age, an argyrosis developed. Ten of these fifteen children were girls. All these children will present throughout their lives a conspicuous and permanent bluish or slate-gray discoloration that will select them as objects of whispered comments by friends and strangers. At present there is no treatment for argyria. The obvious responsibility for this injudicious medication rests with the circularized advertisements by the various manufacturers to the physicians; for example, they say: Argyrol solution, in any strength, may be used in the throat, nose and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

CLINICAL SPECTROSCOPY

JAMA , Volume 104 (16) – Apr 20, 1935

Loading next page...
 
/lp/american-medical-association/clinical-spectroscopy-40FLgPE1tw
Publisher
American Medical Association
Copyright
Copyright © 1935 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1935.02760160011004
Publisher site
See Article on Publisher Site

Abstract

The alarming increase of argyrosis leaves little doubt as to our purpose in this report. There has been an accumulation of indubitable clinical evidence which makes it imperative to present before those who prescribe, dispense or use these drugs the danger entailed therein. It must be emphasized that within the past year, following intranasal applications with Argyrol and Neo-Silvol in fifteen children under 10 years of age, an argyrosis developed. Ten of these fifteen children were girls. All these children will present throughout their lives a conspicuous and permanent bluish or slate-gray discoloration that will select them as objects of whispered comments by friends and strangers. At present there is no treatment for argyria. The obvious responsibility for this injudicious medication rests with the circularized advertisements by the various manufacturers to the physicians; for example, they say: Argyrol solution, in any strength, may be used in the throat, nose and

Journal

JAMAAmerican Medical Association

Published: Apr 20, 1935

There are no references for this article.